Ads
related to: treatment of lupus vulgaris- Official HCP Resources
Download professional resources
for you and your practice.
- Safety & Efficacy Data
View safety and efficacy profile
assessed in clinical trials.
- Important Safety Info
Visit Official HCP Website
for full product information.
- Dosing & Administration
See recommendations for dosing
and administration instructions.
- Official HCP Resources
Search results
Results from the WOW.Com Content Network
Lupus vulgaris (also known as tuberculosis luposa [1]) are painful cutaneous tuberculosis skin lesions with nodular appearance, most often on the face around the nose, eyelids, lips, cheeks, ears [2] and neck. It is the most common Mycobacterium tuberculosis skin infection. [3]
Niels Ryberg Finsen (15 December 1860 – 24 September 1904) was a physician and scientist.In 1903, he was awarded the Nobel Prize in Medicine and Physiology "in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science."
The Danish Nobel Prize winner in medicine and physiology, Niels Finsen, pioneered the use of light as a therapy for skin tuberculosis (lupus vulgaris). [6] His creation of the light device “Finsen lamp” as a lupus vulgaris treatment marked the beginning of modern light therapy.
And in that case, the primary culprit is the use of corticosteroids, a first line of treatment for moderate to severe lupus, says Dr. Diane Kamen, a member of the Lupus Foundation of America’s ...
The Centers for Disease Control and Prevention estimates that more than 200,000 people in the U.S. have lupus, though the Lupus Foundation of America puts the total much higher: roughly 1.5 ...
Lupus is a chronic disease that can cause inflammation and pain in any part of the body. The disease impacts about 1.5 million Americans, but women are nine times more likely to develop lupus than ...
Lupus, formally called systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. [1] Symptoms vary among people and may be mild to severe. [ 1 ]
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has presented additional efficacy data from the AURA-LV and AURORA 1 trials of Lupkynis (voclosporin) in lupus nephritis (LN). Aurinia shared the data at ...
Ads
related to: treatment of lupus vulgaris